Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,107 public trials 2,039 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Study in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Subjects, Excluding Those With the 17p Deletion, to Evaluate Debulking Regimens Prior to Initiating Venetoclax Combination Therapy

NCT03406156

Conditions
Chromosome 17 deletion, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +17 more
Locations
  • Arizona Oncology Associates, PC-HOPE /ID# 202335 Tempe, Arizona, United States
  • Rocky Mountain Cancer Centers - Denver Midtown /ID# 202328 Denver, Colorado, United States
  • MidAmerica Division, Inc. /ID# 201099 Kansas City, Missouri, United States
  • Oncology Hematology Care, Inc. /ID# 202397 Cincinnati, Ohio, United States
View all 15 locations
View Trial Details
Completed

Safety & Effectiveness of TENS Weight Management Compared to a Sham

NCT05675384

Conditions
Body Weight, Hemic and Lymphatic Diseases, Immune System Diseases, +16 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • EmVenio Santa Monica, California, United States
  • A New You Miami, Florida, United States
  • Advanced Research for Health Improvement, LLC (ARHI) Naples, Florida, United States
View Trial Details
Completed

A Study of CC-98633, BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells, in Participants With Relapsed and/or Refractory Multiple Myeloma

NCT04394650

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Local Institution - 103 Birmingham, Alabama, United States
  • Local Institution - 111 Phoenix, Arizona, United States
  • Local Institution - 110 Stanford, California, United States
  • Local Institution - 107 Chicago, Illinois, United States
View Trial Details
Completed

A Safety and Preliminary Efficacy Study of CC-99282 in Combination With Obinutuzumab in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT04434196

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations
  • Local Institution - 106 Boston, Massachusetts, United States
  • Local Institution - 104 Columbus, Ohio, United States
  • Local Institution - 101 Portland, Oregon, United States
  • Local Institution - 107 Dallas, Texas, United States
View all 15 locations
View Trial Details
Completed

Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma

NCT02920697

Conditions
B-Cell Non-Hodgkin Lymphoma (NHL), Blood Protein Disorders, Cardiovascular Diseases, +22 more
Locations
  • The Alfred Hospital Malignant Haematology & Stem Cell Transplantation Services Melbourne, Australia
  • Hopital Claude Huriez Lille, France
  • CHU de Nantes Nantes, France
  • Centre hospitalier Lyon Sud Pierre-Bénite, France
View all 18 locations
View Trial Details

Related conditions